PharmaCCX

PharmaCCX, operating as CCX, develops an enterprise software platform for pharmaceutical market access, pricing and contracting. The platform is built around three tools: CCX Planning, for planning, modelling and analysing contract scenarios and collaborating on solutions; Deal Admin, for contract administration, pharma-payer coordination, learning and data sharing; and CCX Digital Negotiation, an invite-only tool intended to compress deal cycles from months to hours. For life sciences customers, the company positions the platform as a replacement for disjointed legacy systems with a single source of truth, real-time intelligence from global and affiliate teams, and modelling for complex, dynamic pricing.

For payers and health systems, CCX provides technical infrastructure to facilitate and administer innovative contracts, reduce administrative burden, increase deal transactability, and support indication-based pricing and confidential rebates. Bloomberg's company profile describes PharmaCCX as providing pharmaceutical technology and market access solutions covering digital negotiation, workflow management and contract scenario analysis for market access teams at payers and pharmaceutical companies in the United States. Earlier descriptions of the company characterised it as a technology exchange platform allowing parties to confidentially express contingent commitments that trigger binding agreements and smart contracts when conditions are met, enabling performance- and indication-based pricing, with an initial focus on European single-payer markets and combination oncology therapies.

Founding story

Founded by Nathan Sigworth and Richard Bergstrom, both with experience in international pharmaceutical markets. Sigworth previously co-founded and led PharmaSecure after researching healthcare access in India and working on serialization infrastructure and policy; Bergstrom was Director General of EFPIA and worked in regulatory affairs at Roche and Novartis. The company was created to apply technology to drug pricing and reimbursement negotiation, which the founders described as otherwise taking months or years to complete manually.

Business model

The company licenses an enterprise software platform to global pharmaceutical companies and to payers and health systems, marketed through demo requests, with one module (CCX Digital Negotiation) offered on an invite-only basis.

Traction

The company states the platform enables access to more than 75 medicines across over 55 countries. Built In Boston lists 7 total employees.

Latest developments

CCX announced a strategic partnership enabling its technology to connect directly to Model N's global pricing solutions, and is recruiting for open roles. Its leadership team comprises CEO and founder Nathan Sigworth, COO Peter Rice, CTO Michael Quinlan and Chief Commercial Officer Scott Oehrlein, supported by an advisory group including former officials from NHS, NICE, CADTH, ICER, pCPA and CMS.